On-Demand CME Videos
Topical Therapies in Acne: Why the Mechanism of Action (MOA) Matters In Practice Decisions Online CME Activity
About
Topical Therapies in Acne: Why the Mechanism of Action (MOA) Matters In Practice Decisions
This activity is supported by an educational grant from SUN Pharma.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
February 28, 2024
March 28, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Summarize the pathophysiology of acne and relevant targets for newly available therapies.
Define the role of newly available topical therapies for treatment of acne.
Identify patients who would benefit from newly available topical acne treatments.
Intended Audience
Faculty
Hilary Baldwin, MD
Director, Acne Treatment and Research Center
Rutgers Robert Wood Johnson Medical Center
New Brunswick, NJ
James Del Rosso, DO
Adjunct Clinical Professor, Dermatology
Touro University Nevada
Henderson, NV
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Advisory Board: Bausch, Galderma, Almirall, SUN, La Roche Posay, Cutera
Consultant: Bausch, Galderma. Almirall, Sun, Cutera
Speakers’ Bureau or Honoraria: Bausch, Galderma, Almirall, SUN, La Roche Posay
Grant/Research Support: Aclaris, Amgen, Anaptys Bio, Arcutis, Athenex, Bausch (Ortho), Biorasi, Botanix, Brickell, Cara Therapeutics, Cassiopea, Dermavant, EPI Health, Galderma, Genentech, Incyte, Janssen, LEO, Lilly, Novan, Pfizer, Ralexar, Sanofi Genzyme Regeneron, Sol-Gel, SUN, Vyne
Consultant: Abbvie, Aclaris, Almirall, Amgen, Arcuits, Bausch (Ortho), Biofrontera, Biopharmx, Blue Creek, BMS, Cassiopea, Dermata, Dermavant, Encore, EPI Health, Evoummune, Ferndale, Galderma, Incyte, Jem Health, LEO, La Roche Posay, Lilly, MC2, Novan, Pfizer, Sanofi Genzyme Regeneron, Sente, Sol-Gel, Sonoma, SUN, UCB, Verrica, Vyne
Speakers’ Bureau or Honoraria: Abbvie, Aclaris, Almiral, Amgen, Bausch (Ortho), Biofrontera, Encore, EPI Health Ferndale, Galderma, Genentech, Jem Health, LEO, Lilly, Pfizer, Sanofi Genzyme Regeneron, SUN, UCB, Verrica, Vyne
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.